New Agents and Therapeutic Combinations for the Frontline Treatment of Peripheral T-Cell Lymphoma

Gain a deeper understanding of evolving frontline approaches for PTCL through this expert-authored activity plus expert commentaries and a clinical trials resource!
person default
Helen Hancock, NP
Steven M. Horwitz, MD


Consider an improved treatment option for your patients with PTCL with these expert recommendations on the use of brentuximab vedotin with CHP in PTCL based on ECHELON 2 study results.

Steven M. Horwitz, MD Released: February 27, 2019

Get expert insights on key findings in PTCL from the 2019 ASCO annual meeting.

Steven M. Horwitz, MD Released: July 22, 2019

Learn expert strategies for assessing and managing peripheral neuropathy, one of the most common adverse events associated with PTCL treatment.

person default Helen Hancock, NP Released: August 27, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by an educational grant from
Seattle Genetics

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?